MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Psychosis"

  • MDS Virtual Congress 2020

    Behavioral and Psychological Symptoms in Patients with Movement Disorders

    M. Kulsum, S. Anand, H. Kumar (Kolkata,, India)

    Objective: To find out the prevalence of neuropsychiatric symptoms in patients with Movement Disorders. To find out the relationship between cognitive impairment and neuropsychiatric symptoms…
  • MDS Virtual Congress 2020

    Risk of Hospital Admission in Patients with Parkinson’s disease Associated Psychosis (1991-2010)

    C. Stang, M. Hajeb, E. Camerucci, P. Turcano, A. Mullan, P. Martin, V. Abler, M. Splett, N. Rashid, J. Bower, M. Mielke, R. Savica (Rochester, MN, USA)

    Objective: To determine indicators for hospital admission in patients with Parkinson's disease (PD) and in patients with Parkinson's disease Psychosis (PDP), and to compare patients…
  • MDS Virtual Congress 2020

    Increased risk of Parkinson’s disease in patients with schizophrenia spectrum disorders

    T. Kuusimäki, H. Al-Abdulrasul, S. Kurki, J. Hietala, S. Hartikainen, M. Koponen, A. Tolppanen, V. Kaasinen (Turku, Finland)

    Objective: To investigate the coincidence of Parkinson’s disease (PD) and schizophrenia spectrum disorders (SCD). Background: PD is characterized by a progressive loss of mesostriatal dopamine…
  • MDS Virtual Congress 2020

    Homer1 polymorphism in patients with Parkinson’s disease and psychosis

    A. Lenka, S. Vadivel, R. Christopher, S. Arumugham, S. Hegde, R. Yadav, P. Pal (Washington, DC, USA)

    Objective: To explore the association of psychosis in Parkinson’s disease with polymorphisms of HOMER1, a gene whose product (Homer1) is responsible for modulating the metabotropic…
  • MDS Virtual Congress 2020

    Attitudes of Care Partners Toward Medications for Parkinson’s Disease Psychosis

    S. Mantri, S. Albert, E. Klawson, L. Alzyoud, M. Daeschler, C. Kopil, C. Marras, L. Chahine (Toronto, ON, Canada)

    Objective: To explore attitudes regarding use of medications among care partners of individuals with Parkinson’s disease psychosis. Background: Parkinson’s disease (PD) psychosis is a highly…
  • MDS Virtual Congress 2020

    Mental Health Matters Too – Integration of physical and mental health in a multidisciplinary Parkinson’s Clinic

    C. Taylor, C. Johnson, J. Marsh, L. Brown, A. Silverwood, R. Stringer, C. Cooper, R. Skelly (Derby, United Kingdom)

    Objective: The overall aim of the project was to demonstrate that people with Parkinson’s disease benefit from good mental health care when mental health services…
  • MDS Virtual Congress 2020

    All-cause mortality in pimavanserin and atypical antipsychotic users with Parkinson’s disease in Medicare

    A. Mosholder, Y. Ma, S. Akhtar, G. Podskalny, Y. Wei, J. Liao, Y. Feng, H. Lyu, M. Wernecke, K. Leishear, L. Nelson, T. MaCurdy, J. Kelman, D. Graham (Silver Spring, MD, USA)

    Objective: To assess all-cause mortality in Medicare beneficiaries with Parkinson’s disease (PD)  receiving pimavanserin or atypical antipsychotics (AAs). Background: In PD patients, the lifetime prevalence…
  • MDS Virtual Congress 2020

    A Systematic Review of the Psychometric Properties of Psychosis Rating Scales in Neurodegenerative Conditions

    P.S Malhotra, Y.M Wan, E.K Tan (London, United Kingdom)

    Objective: To provide an overview of psychosis rating scales validated in specific neurodegenerative disease populations and compare psychometric characteristics of the validated psychosis scales. Background:…
  • 2019 International Congress

    Identifying delirium in people with Parkinson’s disease: the Determine-PD pilot study

    R. Lawson, S. Richardson, A. Yarnall, D. Burn, L. Allan (Newcastle Upon Tyne, United Kingdom)

    Objective: To identify the prevalence of delirium in inpatients with Parkinson’s disease (PD). Background: People with PD may be at increased risk of delirium and…
  • 2019 International Congress

    Comparison of Dementia Patients With and Without Parkinson’s Disease Before Dementia-related Psychosis Occurs: An Administrative Claims Data Analysis

    A. Shim, B. Skoog, V. Abler, N. Rashid, R. Halpern, E. Koep, M. Frazer (San Diego, CA, USA)

    Objective: Describe and compare patients with evidence of dementia-related psychosis diagnosed with Parkinson’s disease with dementia (PDD) versus patients with dementia but no Parkinson’s disease…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 13
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28953 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley